The antigen test is the third sort of test to be approved by the FDA Kumar Jeetendra | May 10, 2020 Presently, the best way to analyze dynamic COVID-19 is to test a patient’s nasal swab for the hereditary material of the infection. While considered profoundly exact, the tests can take hours and require costly, specific hardware basically found at business labs, medical clinics or colleges. A subsequent kind looks in the blood for antibodies, the …
AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes Kumar Jeetendra | August 23, 2020 AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
Study surveys ongoing bits of knowledge into the pathogenesis of feline leukemia virus contamination Kumar Jeetendra | September 10, 2020 Feline leukemia virus (FeLV) is a gammaretrovirus that occurs worldwide in domestic cats, in addition to small wild cats. It’s associated with various severe, and sometimes fatal, diseases including anaemia, immunosuppression and certain cancers. First described over 55 years ago, FeLV has been the topic of intense research interest, which has led to increasingly robust …
New SARS-CoV-2 IgM assay introduced by Beckman Coulter in countries accepting the CE Mark Kumar Jeetendra | November 12, 2020 Beckman Coulter, a medical diagnostics pioneer, today announced the launching of its accessibility SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The brand new IgM antibody test revealed 99.9% specificity with 1,400 negative trials and 100% sensitivity at >18 times post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is …
Study distinguishes protein as likely restorative objective for leishmaniasis vaccine Kumar Jeetendra | December 12, 2020 According to the results of research led by the Complutense University of Madrid (UCM), among the various strategies deployed by the Leishmania parasite to avoid tripping the human immune system is to trigger the SHP-1 protein. The parasite does this by secreting a molecule capable of interacting with the Mincle receptor expressed by antigen-presenting dendritic …
Researchers grow new serological assay for discovery of SARS-CoV-2 antibodies Kumar Jeetendra | December 13, 2020 Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus which causes COVID-19. Rebecca DuBois, associate professor of biomolecular engineering at UC Santa Cruz, said the new method her staff developed is as accurate as the most dependable antibody tests now available, but is less …
High-quality SARS-CoV-2 Antigen Protein Kits Kumar Jeetendra | January 5, 2021 AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development. These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates. SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of …
Putatively juvenile dendritic cells may actuate hearty resistant reactions in young children Kumar Jeetendra | January 20, 2021 A study by Ludwig-Maximilians-Universitaet (LMU) in Munich researchers demonstrates that putatively immature dendritic cells found in young children are able to induce strong immune responses. Dendritic cells are a vital component of the innate immune system, which represents the body’s first line of defense against infectious agents and tumor cells. Their job is to trigger …
ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery Kumar Jeetendra | January 29, 2021 ‘s-Hertogenbosch (The Netherlands) –ENPICOM BV, an innovative bioinformatics software engineering company, announces a major release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module (ADM). This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger …
New gene based vaccine procedure gets award from the Bill and Melinda Gates Foundation Kumar Jeetendra | January 29, 2021 The AAVCOVID vaccine application, a novel gene-based vaccine plan that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. The grant will assist the effort to bring further preclinical validation into the AAV vaccine platform. An AAVCOVID vaccine candidate is set to …
Novel hydrogel gradually delivers RNA nanovaccines to shrivel tumors Kumar Jeetendra | February 18, 2021 Messenger RNA (mRNA) vaccines to stop COVID-19 have made headlines around the world recently, but scientists also have been working on mRNA vaccines to treat or prevent other diseases, including some forms of cancer. Cancer immunotherapy vaccines operate similarly to mRNA vaccines for COVID-19, except they trigger the immune system to attack tumors rather than …
